Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 5 | 2023 | 41 | 2.160 |
Why?
|
| Pregnancy | 38 | 2024 | 3040 | 2.020 |
Why?
|
| Cesarean Section | 5 | 2022 | 147 | 1.490 |
Why?
|
| Pregnancy Complications | 5 | 2021 | 345 | 1.450 |
Why?
|
| Obesity | 8 | 2022 | 972 | 1.210 |
Why?
|
| Obstetrics | 3 | 2018 | 123 | 1.100 |
Why?
|
| Gestational Age | 8 | 2024 | 329 | 1.050 |
Why?
|
| Postpartum Period | 3 | 2022 | 149 | 0.990 |
Why?
|
| Breast Feeding | 3 | 2021 | 105 | 0.830 |
Why?
|
| Cost-Benefit Analysis | 7 | 2015 | 466 | 0.820 |
Why?
|
| Overweight | 2 | 2021 | 119 | 0.750 |
Why?
|
| Infant, Newborn | 9 | 2023 | 2498 | 0.730 |
Why?
|
| Hirschsprung Disease | 1 | 2020 | 12 | 0.710 |
Why?
|
| Tracheal Diseases | 1 | 2020 | 15 | 0.710 |
Why?
|
| Female | 42 | 2024 | 46571 | 0.700 |
Why?
|
| Fetal Diseases | 1 | 2020 | 82 | 0.690 |
Why?
|
| Intellectual Disability | 1 | 2021 | 189 | 0.680 |
Why?
|
| Placenta | 4 | 2023 | 181 | 0.670 |
Why?
|
| Surgical Wound | 1 | 2019 | 6 | 0.670 |
Why?
|
| Electrocardiography | 1 | 2022 | 497 | 0.670 |
Why?
|
| Patient Discharge | 1 | 2022 | 326 | 0.670 |
Why?
|
| Tissue Adhesives | 1 | 2019 | 23 | 0.660 |
Why?
|
| Pregnancy in Diabetics | 2 | 2022 | 38 | 0.660 |
Why?
|
| Labor, Obstetric | 1 | 2019 | 46 | 0.650 |
Why?
|
| Child Development | 1 | 2021 | 167 | 0.650 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2019 | 54 | 0.650 |
Why?
|
| Postpartum Hemorrhage | 2 | 2022 | 26 | 0.640 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 234 | 0.630 |
Why?
|
| Health Care Costs | 3 | 2014 | 236 | 0.630 |
Why?
|
| Suture Techniques | 1 | 2019 | 144 | 0.610 |
Why?
|
| Aneuploidy | 2 | 2016 | 57 | 0.590 |
Why?
|
| Prenatal Diagnosis | 2 | 2016 | 110 | 0.570 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 105 | 0.550 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2024 | 119 | 0.540 |
Why?
|
| Health Personnel | 1 | 2018 | 214 | 0.530 |
Why?
|
| Term Birth | 1 | 2015 | 8 | 0.510 |
Why?
|
| Anesthesia, Epidural | 1 | 2015 | 32 | 0.500 |
Why?
|
| Humans | 45 | 2024 | 89924 | 0.500 |
Why?
|
| Adult | 27 | 2024 | 26810 | 0.490 |
Why?
|
| Body Mass Index | 7 | 2021 | 776 | 0.480 |
Why?
|
| Cesarean Section, Repeat | 1 | 2014 | 3 | 0.460 |
Why?
|
| Trial of Labor | 1 | 2014 | 5 | 0.460 |
Why?
|
| Labor Stage, Second | 3 | 2022 | 6 | 0.460 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2014 | 7 | 0.460 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2014 | 42 | 0.450 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 114 | 0.440 |
Why?
|
| Prospective Studies | 10 | 2023 | 4325 | 0.440 |
Why?
|
| Serpins | 2 | 2014 | 31 | 0.420 |
Why?
|
| Nerve Growth Factors | 2 | 2014 | 63 | 0.420 |
Why?
|
| Hepatitis C | 2 | 2005 | 174 | 0.410 |
Why?
|
| Misoprostol | 2 | 2024 | 15 | 0.400 |
Why?
|
| Labor, Induced | 2 | 2024 | 30 | 0.400 |
Why?
|
| Glucose Tolerance Test | 2 | 2023 | 227 | 0.390 |
Why?
|
| Eye Proteins | 2 | 2014 | 128 | 0.390 |
Why?
|
| Cardiotocography | 2 | 2022 | 7 | 0.380 |
Why?
|
| Pregnancy Outcome | 4 | 2024 | 258 | 0.380 |
Why?
|
| Oxytocics | 2 | 2022 | 24 | 0.360 |
Why?
|
| Pre-Eclampsia | 2 | 2024 | 255 | 0.350 |
Why?
|
| DNA | 1 | 2016 | 1311 | 0.350 |
Why?
|
| Hospitalization | 1 | 2015 | 888 | 0.340 |
Why?
|
| Cohort Studies | 9 | 2024 | 2887 | 0.320 |
Why?
|
| Stillbirth | 1 | 2008 | 10 | 0.310 |
Why?
|
| Infant | 3 | 2021 | 3189 | 0.300 |
Why?
|
| Quality Improvement | 2 | 2022 | 457 | 0.290 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2024 | 70 | 0.290 |
Why?
|
| Weight Gain | 3 | 2020 | 119 | 0.280 |
Why?
|
| Placenta Growth Factor | 2 | 2024 | 70 | 0.270 |
Why?
|
| Retrospective Studies | 10 | 2024 | 9203 | 0.270 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2024 | 94 | 0.260 |
Why?
|
| Mass Screening | 3 | 2013 | 646 | 0.260 |
Why?
|
| Delivery, Obstetric | 2 | 2022 | 120 | 0.260 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2005 | 64 | 0.240 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2004 | 48 | 0.230 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 2 | 2024 | 11 | 0.230 |
Why?
|
| Abortion, Induced | 2 | 2024 | 138 | 0.220 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2003 | 16 | 0.220 |
Why?
|
| Bupivacaine | 1 | 2003 | 45 | 0.220 |
Why?
|
| Analgesia, Epidural | 1 | 2003 | 38 | 0.210 |
Why?
|
| C-Peptide | 1 | 2023 | 179 | 0.210 |
Why?
|
| Sex | 1 | 2002 | 6 | 0.200 |
Why?
|
| Labor Stage, First | 1 | 2022 | 3 | 0.200 |
Why?
|
| Logistic Models | 3 | 2022 | 1214 | 0.200 |
Why?
|
| Patient Satisfaction | 2 | 2003 | 460 | 0.200 |
Why?
|
| Fetal Hypoxia | 1 | 2022 | 14 | 0.200 |
Why?
|
| Decision Trees | 3 | 2014 | 60 | 0.200 |
Why?
|
| Fetus | 1 | 2023 | 232 | 0.200 |
Why?
|
| Checklist | 1 | 2022 | 64 | 0.200 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2014 | 144 | 0.190 |
Why?
|
| Premature Birth | 1 | 2023 | 120 | 0.190 |
Why?
|
| Wechsler Scales | 1 | 2021 | 21 | 0.190 |
Why?
|
| Oxytocin | 1 | 2022 | 73 | 0.190 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 77 | 0.190 |
Why?
|
| Thinness | 1 | 2021 | 46 | 0.190 |
Why?
|
| Hypotension | 1 | 2021 | 71 | 0.180 |
Why?
|
| Glucose | 1 | 2023 | 629 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2022 | 353 | 0.180 |
Why?
|
| Gynecology | 1 | 2002 | 130 | 0.170 |
Why?
|
| Goals | 1 | 2020 | 67 | 0.170 |
Why?
|
| United States | 5 | 2024 | 7102 | 0.170 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 15 | 0.170 |
Why?
|
| Fetofetal Transfusion | 1 | 2019 | 8 | 0.170 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 24 | 0.170 |
Why?
|
| Pain Management | 1 | 2020 | 143 | 0.160 |
Why?
|
| Perinatal Care | 1 | 2018 | 20 | 0.160 |
Why?
|
| Prenatal Care | 3 | 2013 | 77 | 0.150 |
Why?
|
| Exercise | 2 | 2018 | 328 | 0.150 |
Why?
|
| Education, Medical, Continuing | 1 | 2018 | 106 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 682 | 0.140 |
Why?
|
| Biomarkers | 1 | 2024 | 1775 | 0.140 |
Why?
|
| Decision Support Techniques | 3 | 2015 | 168 | 0.140 |
Why?
|
| Risk Factors | 3 | 2024 | 5554 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2018 | 234 | 0.140 |
Why?
|
| Counseling | 1 | 2018 | 166 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 451 | 0.130 |
Why?
|
| Genetic Testing | 2 | 2012 | 542 | 0.130 |
Why?
|
| Mouth Mucosa | 1 | 2016 | 68 | 0.130 |
Why?
|
| Urolithiasis | 1 | 2015 | 4 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2653 | 0.130 |
Why?
|
| Ureteroscopy | 1 | 2015 | 38 | 0.130 |
Why?
|
| Fathers | 1 | 2016 | 72 | 0.120 |
Why?
|
| Male | 6 | 2023 | 42657 | 0.120 |
Why?
|
| Physicians | 1 | 2002 | 691 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2016 | 301 | 0.120 |
Why?
|
| Pregnancy Trimester, First | 3 | 2023 | 63 | 0.120 |
Why?
|
| Maternal Mortality | 1 | 2014 | 15 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2014 | 59 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2021 | 3769 | 0.110 |
Why?
|
| Models, Economic | 1 | 2014 | 62 | 0.110 |
Why?
|
| Patient Simulation | 1 | 2013 | 42 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 539 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 58 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 186 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 983 | 0.110 |
Why?
|
| Rubella virus | 1 | 2013 | 2 | 0.110 |
Why?
|
| Rubella | 1 | 2013 | 3 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 111 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 654 | 0.110 |
Why?
|
| Weight Loss | 1 | 2015 | 233 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 608 | 0.110 |
Why?
|
| Antigens, Viral | 1 | 2013 | 145 | 0.100 |
Why?
|
| Stents | 1 | 2015 | 412 | 0.100 |
Why?
|
| Abortion, Habitual | 1 | 2012 | 33 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1054 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2014 | 262 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2022 | 405 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2014 | 464 | 0.090 |
Why?
|
| Prostate | 1 | 2014 | 402 | 0.090 |
Why?
|
| Adolescent | 5 | 2023 | 9339 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2013 | 351 | 0.080 |
Why?
|
| Echocardiography | 1 | 2014 | 944 | 0.080 |
Why?
|
| Age Distribution | 2 | 2007 | 199 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 1859 | 0.080 |
Why?
|
| Time Factors | 3 | 2024 | 5357 | 0.080 |
Why?
|
| Probability | 2 | 2013 | 350 | 0.080 |
Why?
|
| Preimplantation Diagnosis | 1 | 2007 | 5 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2013 | 795 | 0.070 |
Why?
|
| Young Adult | 5 | 2024 | 6408 | 0.070 |
Why?
|
| Live Birth | 1 | 2007 | 18 | 0.070 |
Why?
|
| Genetic Counseling | 1 | 2007 | 102 | 0.070 |
Why?
|
| Middle Aged | 3 | 2023 | 26132 | 0.070 |
Why?
|
| Infertility, Female | 1 | 2007 | 96 | 0.070 |
Why?
|
| Neural Tube Defects | 1 | 2007 | 45 | 0.070 |
Why?
|
| Women's Health | 1 | 2007 | 103 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 293 | 0.060 |
Why?
|
| Postnatal Care | 1 | 2005 | 27 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 128 | 0.060 |
Why?
|
| Uterine Rupture | 1 | 2024 | 7 | 0.060 |
Why?
|
| Chorioamnionitis | 1 | 2024 | 21 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2013 | 1062 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 364 | 0.060 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2003 | 28 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2313 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 50 | 0.050 |
Why?
|
| Parity | 1 | 2003 | 97 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 595 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 168 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2022 | 56 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2022 | 30 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1738 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 174 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 662 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2003 | 332 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 778 | 0.050 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 29 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 358 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2020 | 29 | 0.050 |
Why?
|
| Incidence | 1 | 2005 | 1601 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 56 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2020 | 57 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1250 | 0.040 |
Why?
|
| Pregnancy, Twin | 1 | 2019 | 8 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 1731 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 312 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1469 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 837 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 256 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 778 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 981 | 0.040 |
Why?
|
| Length of Stay | 1 | 2020 | 748 | 0.040 |
Why?
|
| Suburban Population | 1 | 2016 | 6 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 37 | 0.030 |
Why?
|
| Phenotype | 1 | 2022 | 2457 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 3680 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1929 | 0.030 |
Why?
|
| Saliva | 1 | 2016 | 124 | 0.030 |
Why?
|
| Rural Population | 1 | 2016 | 147 | 0.030 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 39 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 225 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2007 | 8270 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 82 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 103 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2016 | 322 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2012 | 5 | 0.030 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 71 | 0.030 |
Why?
|
| Cost Savings | 1 | 2012 | 70 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 871 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1729 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 386 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1669 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2007 | 45 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3796 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2007 | 186 | 0.020 |
Why?
|
| Illinois | 1 | 2007 | 485 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1908 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3470 | 0.010 |
Why?
|
| Child | 1 | 2013 | 7242 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 27526 | 0.010 |
Why?
|